Baxter Bros Inc’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.44M | Buy |
18,827
+282
| +2% | +$135K | 1.09% | 26 |
|
|
2026
Q1 | $9.12M | Sell |
18,545
-678
| -4% | -$368K | 1.13% | 27 |
|
|
2025
Q4 | $11.1M | Sell |
19,223
-1,414
| -7% | -$800K | 1.29% | 23 |
|
|
2025
Q3 | $10M | Sell |
20,637
-447
| -2% | -$208K | 1.16% | 25 |
|
|
2025
Q2 | $8.55M | Sell |
21,084
-5,772
| -21% | -$2.41M | 1.05% | 27 |
|
|
2025
Q1 | $13.4M | Sell |
26,856
-1,606
| -6% | -$870K | 1.76% | 17 |
|
|
2024
Q4 | $14.8M | Buy |
28,462
+432
| +2% | +$238K | 1.94% | 16 |
|
|
2024
Q3 | $17.3M | Sell |
28,030
-518
| -2% | -$307K | 2.25% | 13 |
|
|
2024
Q2 | $15.8M | Sell |
28,548
-595
| -2% | -$341K | 2.07% | 15 |
|
|
2024
Q1 | $16.9M | Sell |
29,143
-88
| -0.3% | -$49.4K | 2.17% | 15 |
|
|
2023
Q4 | $15.5M | Sell |
29,231
-154
| -0.5% | -$74.5K | 2.15% | 12 |
|
|
2023
Q3 | $14.9M | Sell |
29,385
-34
| -0.1% | -$18.1K | 2.26% | 13 |
|
|
2023
Q2 | $15.3M | Sell |
29,419
-130
| -0.4% | -$70.2K | 2.28% | 11 |
|
|
2023
Q1 | $17M | Sell |
29,549
-880
| -3% | -$496K | 2.68% | 10 |
|
|
2022
Q4 | $16.8M | Sell |
30,429
-1,052
| -3% | -$557K | 2.75% | 8 |
|
|
2022
Q3 | $16M | Sell |
31,481
-375
| -1% | -$210K | 2.83% | 10 |
|
|
2022
Q2 | $17.3M | Buy |
31,856
+51
| +0.2% | +$28.1K | 3.11% | 9 |
|
|
2022
Q1 | $18.8M | Sell |
31,805
-412
| -1% | -$237K | 2.82% | 9 |
|
|
2021
Q4 | $21.5M | Sell |
32,217
-145
| -0.4% | -$90.5K | 3.12% | 9 |
|
|
2021
Q3 | $18.5M | Sell |
32,362
-826
| -2% | -$453K | 2.96% | 9 |
|
|
2021
Q2 | $16.7M | Sell |
33,188
-19
| -0.1% | -$8.96K | 2.65% | 10 |
|
|
2021
Q1 | $15.2M | Sell |
33,207
-668
| -2% | -$319K | 2.6% | 12 |
|
|
2020
Q4 | $15.8M | Buy |
33,875
+145
| +0.4% | +$68K | 2.99% | 9 |
|
|
2020
Q3 | $14.9M | Sell |
33,730
-1,419
| -4% | -$586K | 3.22% | 8 |
|
|
2020
Q2 | $12.7M | Buy |
35,149
+1,440
| +4% | +$483K | 2.99% | 8 |
|
|
2020
Q1 | $9.56M | Buy |
33,709
+2,780
| +9% | +$877K | 2.48% | 9 |
|
|
2019
Q4 | $10M | Buy |
30,929
+2,024
| +7% | +$614K | 2.09% | 12 |
|
|
2019
Q3 | $8.42M | Sell |
28,905
-1,139
| -4% | -$326K | 1.91% | 15 |
|
|
2019
Q2 | $8.82M | Buy |
30,044
+444
| +2% | +$122K | 2.02% | 12 |
|
|
2019
Q1 | $8.1M | Buy |
29,600
+630
| +2% | +$157K | 1.89% | 16 |
|
|
2018
Q4 | $6.48M | Buy |
28,970
+361
| +1% | +$84.7K | 1.76% | 17 |
|
|
2018
Q3 | $6.98M | Buy |
28,609
+3,995
| +16% | +$919K | 1.68% | 18 |
|
|
2018
Q2 | $5.1M | Buy |
24,614
+2,019
| +9% | +$429K | 1.37% | 24 |
|
|
2018
Q1 | $4.67M | Buy |
22,595
+1,059
| +5% | +$222K | 1.27% | 25 |
|
|
2017
Q4 | $4.09M | Buy |
21,536
+946
| +5% | +$181K | 1.12% | 31 |
|
|
2017
Q3 | $3.9M | Buy |
20,590
+1,336
| +7% | +$242K | 1.12% | 28 |
|
|
2017
Q2 | $3.36M | Buy |
19,254
+1,929
| +11% | +$324K | 1.01% | 31 |
|
|
2017
Q1 | $2.66M | Buy |
17,325
+4,635
| +37% | +$708K | 0.83% | 36 |
|
|
2016
Q4 | $1.79M | Buy |
12,690
+171
| +1% | +$25.2K | 0.58% | 42 |
|
|
2016
Q3 | $1.99M | Sell |
12,519
-750
| -6% | -$116K | 0.67% | 39 |
|
|
2016
Q2 | $1.96M | Buy |
+13,269
| New | +$1.96M | 0.69% | 41 |
|
|
2015
Q4 | $1.68M | Buy |
11,836
+1,449
| +14% | +$193K | 0.62% | 43 |
|
|
2015
Q3 | $1.35M | Hold |
10,387
| – | – | 0.49% | 49 |
|
|
2015
Q2 | $1.35M | Sell |
10,387
-217
| -2% | -$28.3K | 0.49% | 49 |
|
|
2015
Q1 | $1.43M | Hold |
10,604
| – | – | 0.52% | 49 |
|
|
2014
Q4 | $1.33M | Buy |
10,604
+32
| +0.3% | +$3.89K | 0.48% | 48 |
|
|
2014
Q3 | $1.29M | Buy |
10,572
+956
| +10% | +$116K | 0.5% | 49 |
|
|
2014
Q2 | $1.14M | Buy |
9,616
+119
| +1% | +$14K | 0.47% | 50 |
|
|
2014
Q1 | $1.14M | Hold |
9,497
| – | – | 0.52% | 47 |
|
|
2013
Q4 | $1.06M | Sell |
9,497
-200
| -2% | -$19.9K | 0.5% | 48 |
|
|
2013
Q3 | $894K | Buy |
9,697
+5,000
| +106% | +$452K | 0.49% | 47 |
|
|
2013
Q2 | $398K | Buy |
+4,697
| New | +$391K | 0.24% | 59 |
|
Other funds holding TMO
Baxter Bros Inc's TMO Position: Q2 2026 in Review
Baxter Bros Inc increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q2 2026, buying an estimated $135K and bringing the position to 18,827 shares worth $9.44M. The position accounts for 1.09% of the portfolio, ranked #26.
Baxter Bros Inc first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.5M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Baxter Bros Inc held 18,827 shares of Thermo Fisher Scientific worth $9.44M as of Q2 2026.
- Baxter Bros Inc bought 282 Thermo Fisher Scientific shares in Q2 2026, an estimated $135K.
- Thermo Fisher Scientific made up 1.09% of Baxter Bros Inc's portfolio in Q2 2026, its #26 holding.
- Baxter Bros Inc first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Baxter Bros Inc's Thermo Fisher Scientific position peaked at $21.5M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.